Malak Alharbi, Hematology/Oncology fellow at Roswell Park, shared on X:
“Rare cancers account for ~27% of newly diagnosed cancers. We still need to understand the risk factors for NET (neuroendocrine tumors). Thus, the importance of biobanking and access to research!! A great comprehensive review by Dr. Renuka Iyer at Upstate NY Cancer Symposium.”
Source: Malak Alharbi/X
